Darunavir(DRV)/r-Based PEP Versus Standard of Care (SOC) – the Randomized PEPDar Study
Background: Post exposure prophylaxis (PEP) for 4 weeks is state-of-the-art following exposure to HIV with high risk of transmission. None of the recommended regimens has been studied in prospective randomized studies in this indication so far, discontinuations rates due to side effects are high. Darunavir/r has a favorable safety profile and high antiviral potency. It…